Drug common name | DOLCANATIDE |
INN | dolcanatide |
Description | Dolcanatide is a protein pharmaceutical. It is currently being investigated in clinical studies. It is known to target guanylyl cyclase C. |
Classification | Protein |
Drug class | peptides |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(C)C[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](N)CC(N)=O)CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](CC(C)C)C(=O)O)CSSC[C@@H](C(=O)N[C@H](C(=O)O)C(C)C)NC1=O |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL3545122 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | WU977T914K (ChemIDplus, GSRS) |